tiprankstipranks
Advertisement
Advertisement

PYPD Stock Latest News

PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
Company AnnouncementsPolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
16d ago
6K
PYPD
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
PremiumTipRanks Newswire
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
16d ago
APLS
PYPD
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
PremiumTipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
29d ago
CING
OVID
PolyPid granted $4.3M waiver from FDA for D-Plex application
PremiumThe Fly
PolyPid granted $4.3M waiver from FDA for D-Plex application
1M ago
PYPD
PolyPid Earnings Call Flags Big 2026 Catalyst
PremiumCompany Announcements
PolyPid Earnings Call Flags Big 2026 Catalyst
2M ago
PYPD
PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
PremiumRatingsPolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
2M ago
PYPD
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
2M ago
PYPD
Ten new option listings and two option delistings on January 22nd
Premium
The Fly
Ten new option listings and two option delistings on January 22nd
3M ago
AVR
INR
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
PremiumCompany Announcements
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
4M ago
6K
PYPD
PolyPid Appoints Brooke Story as Chairman Amid Strategic Growth
PremiumCompany Announcements
PolyPid Appoints Brooke Story as Chairman Amid Strategic Growth
4M ago
6K
PYPD
PolyPid appoints Story as Chairman of Board of Directors
PremiumThe Fly
PolyPid appoints Story as Chairman of Board of Directors
4M ago
PYPD
Roth Capital healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Roth Capital healthcare analyst holds an analyst/industry conference call
4M ago
BDX
JNJ
PolyPid Gains FDA Support for D-PLEX100 NDA Submission
PremiumCompany AnnouncementsPolyPid Gains FDA Support for D-PLEX100 NDA Submission
4M ago
6K
PYPD
PolyPid receives pre-NDA meeting minutes for D-Plex supporting NDA submission
Premium
The Fly
PolyPid receives pre-NDA meeting minutes for D-Plex supporting NDA submission
4M ago
PYPD
PolyPid Expands Share Offering to Strengthen Financial Position
Premium
Company Announcements
PolyPid Expands Share Offering to Strengthen Financial Position
5M ago
6K
PYPD
PolyPid price target lowered to $9 from $10 at Roth Capital
PremiumThe Fly
PolyPid price target lowered to $9 from $10 at Roth Capital
5M ago
PYPD
PolyPid Ltd. Advances Towards Key Milestones in 2025
PremiumCompany Announcements
PolyPid Ltd. Advances Towards Key Milestones in 2025
5M ago
PYPD
PolyPid Ltd. Earnings Call: Progress and Potential
PremiumCompany Announcements
PolyPid Ltd. Earnings Call: Progress and Potential
5M ago
PYPD
PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline
PremiumRatings
PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline
5M ago
PYPD
PolyPid Advances D-PLEX₁₀₀ Towards FDA Submission and Commercial Readiness
PremiumCompany AnnouncementsPolyPid Advances D-PLEX₁₀₀ Towards FDA Submission and Commercial Readiness
5M ago
6K
PYPD
PolyPid sees cash runway ‘well into’ 2026
Premium
The Fly
PolyPid sees cash runway ‘well into’ 2026
5M ago
PYPD
PolyPid reports Q3 EPS (37c), consensus (52c)
Premium
The Fly
PolyPid reports Q3 EPS (37c), consensus (52c)
5M ago
PYPD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >